Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study.
Nicolucci A, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Khunti K, Kosiborod M, Leigh P, Medin J, Rathmann W, Shestakova MV, Shimomura I, Siddiqui A, Tang F, Watada H, Ji L; DISCOVER investigators. Nicolucci A, et al. Among authors: siddiqui a. Diabetes Res Clin Pract. 2021 Oct;180:108974. doi: 10.1016/j.diabres.2021.108974. Epub 2021 Jul 22. Diabetes Res Clin Pract. 2021. PMID: 34302913
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Khunti K, Charbonnel B, Cooper A, Gomes MB, Ji L, Leigh P, Nicolucci A, Rathmann W, Shestakova MV, Siddiqui A, Tang F, Watada H, Chen H; DISCOVER investigators. Khunti K, et al. Among authors: siddiqui a. Diabetes Obes Metab. 2021 Aug;23(8):1823-1833. doi: 10.1111/dom.14400. Epub 2021 May 3. Diabetes Obes Metab. 2021. PMID: 33852202
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Bonnet F, Chen H, Cooper A, Gomes MB, Ji L, Leigh P, Ramirez L, Shestakova MV, Shimomura I, Siddiqui A, Tang F, Vora J, Watada H, Khunti K. Bonnet F, et al. Among authors: siddiqui a. Diabetes Obes Metab. 2021 Oct;23(10):2336-2343. doi: 10.1111/dom.14476. Epub 2021 Aug 2. Diabetes Obes Metab. 2021. PMID: 34212481
Prediction of cardiovascular risk factors from retinal fundus photographs: Validation of a deep learning algorithm in a prospective non-interventional study in Kenya.
White T, Selvarajah V, Wolfhagen-Sand F, Svangård N, Mohankumar G, Fenici P, Rough K, Onyango N, Lyons K, Mack C, Nduba V, Noorali Saleh M, Abayo I, Siddiqui A, Majdanska-Strzalka M, Kaszubska K, Hegelund-Myrback T, Esterline R, Manzur A, Parker VER. White T, et al. Among authors: siddiqui a. Diabetes Obes Metab. 2024 Jul;26(7):2722-2731. doi: 10.1111/dom.15587. Epub 2024 Apr 15. Diabetes Obes Metab. 2024. PMID: 38618987
Insulinoma; a diagnostic challenge: a case report.
Rafaey W, Alvi AM, Aslam S, Siddiqui AI, Shafiq W. Rafaey W, et al. Among authors: siddiqui ai. J Pak Med Assoc. 2025 Jan;75(1):122-124. doi: 10.47391/JPMA.11001. J Pak Med Assoc. 2025. PMID: 39828844
Doctors taking bribes from pharmaceutical companies is common and not substantially reduced by an educational intervention: a pragmatic randomised controlled trial in Pakistan.
Khan M, Noor MN, Rahman-Shepherd A, Siddiqui AR, Khan SS, van der Mark N, Isani AK, Siddiqi AQ, Opondo C, Ziauddin F, Bhutto F, Azam I, Hanefeld J, Ali N, Khan RI, Kazmi SAR, Wiseman V, Aftab W, Mirza Z, Hasan Z, Siddiqi S, Hasan R, Shakoor S. Khan M, et al. Among authors: siddiqui ar. BMJ Glob Health. 2025 Jan 15;9(12):e016055. doi: 10.1136/bmjgh-2024-016055. BMJ Glob Health. 2025. PMID: 39819661 Free article. Clinical Trial.
Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.
Geyer CE Jr, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, D'Hondt V, Conlin AK, Guarneri V, Wapnir IL, Jackisch C, Arce-Salinas C, Fasching PA, DiGiovanna MP, Crown JP, Wuelfing P, Shao Z, Rota Caremoli E, Bonnefoi HR, Hennessy BT, Stamatovic L, Castro-Salguero H, Brufsky AM, Knott A, Siddiqui A, Lambertini C, Boulet T, Nyawira B, Restuccia E, Loibl S; KATHERINE Study Group. Geyer CE Jr, et al. Among authors: siddiqui a. N Engl J Med. 2025 Jan 16;392(3):249-257. doi: 10.1056/NEJMoa2406070. N Engl J Med. 2025. PMID: 39813643 Clinical Trial.
3,288 results